Viz.Ai Wins 2024 Edison Award™ for Innovation for Second Year in a Row

"When we started Viz.ai, we had a vision that by using artificial intelligence, we could help healthcare systems work smarter and faster, improving patient outcomes and ultimately saving lives," says Chris Mansi, CEO and co-founder of Viz.ai, which has just been named an Edison Award winner for the second year in a row.

The artificial intelligence software company's Viz PE with automated RV/LV ratio measurement became an FDA-cleared AI-powered solution for the detection of suspected pulmonary embolism (PE) and assessment of right heart strain in 2022, in partnership with Avicenna.AI, per a press release.

Pulmonary embolism is a serious condition, with untreated acute cases having a mortality rate as high as 30% within one month of diagnosis.

The Viz PE solution combines Viz.ai's AI software with the Pulmonary Embolism Response Team's (PERT) activation, which "significantly improved time to assessment and time to anticoagulation with a 74% reduction in in-hospital risk," per the American Lung Association.

Viz.ai One is an intelligent care coordination solution that uses AI algorithms and machine learning to increase the speed of diagnosis and care across 1,600+ hospitals and health systems in the US.

Viz.ai was founded in 2014 by Mansi

Read the Entire Article